Literature DB >> 20336164

Diabetes: treatment of type 2 diabetes mellitus with bariatric surgery.

Peter Clifton.   

Abstract

Gastrointestinal surgery may ameliorate glycemic control in type 2 diabetes mellitus within days to weeks--an effect that cannot be explained solely by the changes in food intake and body weight following gastric bypass. should clinicians, therefore, implement bariatric procedures to treat type 2 diabetes mellitus in patients who do not meet current obesity-based criteria for surgery?

Entities:  

Mesh：

Year:  2010        PMID： 20336164     DOI： 10.1038/nrendo.2010.23

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


  10 in total

Review 1.  Laparoscopic adjustable gastric banding in the treatment of obesity: a systematic literature review.

Authors:  Andrew E Chapman; George Kiroff; Philip Game; Bruce Foster; Paul O'Brien; John Ham; Guy J Maddern
Journal:  Surgery       Date:  2004-03       Impact factor: 3.982

2.  Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery.

Authors:  Lars Sjöström; Anna-Karin Lindroos; Markku Peltonen; Jarl Torgerson; Claude Bouchard; Björn Carlsson; Sven Dahlgren; Bo Larsson; Kristina Narbro; Carl David Sjöström; Marianne Sullivan; Hans Wedel
Journal:  N Engl J Med       Date:  2004-12-23       Impact factor: 91.245

Review 3.  The Diabetes Surgery Summit consensus conference: recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus.

Authors:  Francesco Rubino; Lee M Kaplan; Philip R Schauer; David E Cummings
Journal:  Ann Surg       Date:  2010-03       Impact factor: 12.969

4.  Laparoscopic adjustable gastric banding versus Roux-en-Y gastric bypass: 5-year results of a prospective randomized trial.

Authors:  Luigi Angrisani; Michele Lorenzo; Vincenzo Borrelli
Journal:  Surg Obes Relat Dis       Date:  2007-02-27       Impact factor: 4.734

Review 5.  Changes in insulin resistance following bariatric surgery: role of caloric restriction and weight loss.

Authors:  Andrew A Gumbs; Irvin M Modlin; Garth H Ballantyne
Journal:  Obes Surg       Date:  2005-04       Impact factor: 4.129

Review 6.  Gastric banding or bypass? A systematic review comparing the two most popular bariatric procedures.

Authors:  Jeffrey A Tice; Leah Karliner; Judith Walsh; Amy J Petersen; Mitchell D Feldman
Journal:  Am J Med       Date:  2008-10       Impact factor: 4.965

7.  Weight loss and changes in use of antidiabetic medication in obese type 2 diabetics after laparoscopic gastric banding.

Authors:  Gianni Segato; Luca Busetto; Maurizio De Luca; Fabio De Stefano; Mariangela Marangon; Stefano Salvalaio; David Ashton; Franco Favretti; Giuliano Enzi
Journal:  Surg Obes Relat Dis       Date:  2009-10-03       Impact factor: 4.734

Review 8.  Bariatric surgery: a systematic review and meta-analysis.

Authors:  Henry Buchwald; Yoav Avidor; Eugene Braunwald; Michael D Jensen; Walter Pories; Kyle Fahrbach; Karen Schoelles
Journal:  JAMA       Date:  2004-10-13       Impact factor: 56.272

Review 9.  Endocrine and metabolic response to gastric bypass.

Authors:  Jabbar Saliba; Julia Wattacheril; Naji N Abumrad
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2009-09       Impact factor: 4.294

10.  Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial.

Authors:  John B Dixon; Paul E O'Brien; Julie Playfair; Leon Chapman; Linda M Schachter; Stewart Skinner; Joseph Proietto; Michael Bailey; Margaret Anderson
Journal:  JAMA       Date:  2008-01-23       Impact factor: 56.272
  10 in total
  7 in total

1.  Effects of RS9939609 gene variant in FTO gene on weight loss and cardiovascular risk factors after biliopancreatic diversion surgery.

Authors:  Daniel Antonio de Luis; Rocío Aller; Rosa Conde; Olatz Izaola; David Pacheco; Manuel Gonzalez Sagrado; David Primo
Journal:  J Gastrointest Surg       Date:  2012-02-04       Impact factor: 3.452

Review 2.  Metabolomics and Metabolic Diseases: Where Do We Stand?

Authors:  Christopher B Newgard
Journal:  Cell Metab       Date:  2016-10-27       Impact factor: 27.287

3.  ESR1, FTO, and UCP2 genes interact with bariatric surgery affecting weight loss and glycemic control in severely obese patients.

Authors:  Tsan-Hon Liou; Hsin-Hung Chen; Weu Wang; Shu-Fen Wu; Yi-Chih Lee; Wei-Shiung Yang; Wei-Jei Lee
Journal:  Obes Surg       Date:  2011-11       Impact factor: 4.129

4.  The effect of rs9939609 FTO gene polymorphism on weight loss after laparoscopic sleeve gastrectomy.

Authors:  Özgür Balasar; Tuğrul Çakır; Özgür Erkal; Arif Aslaner; Bülent Çekiç; Mehmet Uyar; Nurullah Bülbüller; Mehmet Tahir Oruç
Journal:  Surg Endosc       Date:  2015-03-24       Impact factor: 4.584

Review 5.  Metabolomic profiling for the identification of novel biomarkers and mechanisms related to common cardiovascular diseases: form and function.

Authors:  Svati H Shah; William E Kraus; Christopher B Newgard
Journal:  Circulation       Date:  2012-08-28       Impact factor: 29.690

Review 6.  Interplay between lipids and branched-chain amino acids in development of insulin resistance.

Authors:  Christopher B Newgard
Journal:  Cell Metab       Date:  2012-05-02       Impact factor: 27.287

7.  Catabolism of Branched Chain Amino Acids Contributes Significantly to Synthesis of Odd-Chain and Even-Chain Fatty Acids in 3T3-L1 Adipocytes.

Authors:  Scott B Crown; Nicholas Marze; Maciek R Antoniewicz
Journal:  PLoS One       Date:  2015-12-28       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.